Maria became the global head of ZS’s pharmaceutical and biotech business in July 2021, which comprises 85% of ZS’s work. She has been part of the firm’s life sciences leadership team for eight years, previously leading the global oncology and specialty vertical, working with over 20 companies a year and building a team that on average supports about 90% of all oncology launches. She founded and led core expertise verticals, including cell and gene therapy, and has sponsored the advancement of ZS’s work in areas such as rare diseases and biosimilars. With more than 20 years in healthcare, Maria has advi...read more